85 related articles for article (PubMed ID: 29489494)
1. Mineralocorticoid receptor-related markers and outcome of major depression: focus on blood pressure and electrolytes.
Murck H; Ploch M; Montgomery S
Int Clin Psychopharmacol; 2018 Jul; 33(4):224-228. PubMed ID: 29489494
[TBL] [Abstract][Full Text] [Related]
2. Target-based biomarker selection - Mineralocorticoid receptor-related biomarkers and treatment outcome in major depression.
Büttner M; Jezova D; Greene B; Konrad C; Kircher T; Murck H
J Psychiatr Res; 2015; 66-67():24-37. PubMed ID: 25959615
[TBL] [Abstract][Full Text] [Related]
3. Markers of mineralocorticoid receptor function: changes over time and relationship to response in patients with major depression.
Murck H; Braunisch MC; Konrad C; Jezova D; Kircher T
Int Clin Psychopharmacol; 2019 Jan; 34(1):18-26. PubMed ID: 30300165
[TBL] [Abstract][Full Text] [Related]
4. St. John's wort extract LI160 for the treatment of depression with atypical features - a double-blind, randomized, and placebo-controlled trial.
Mannel M; Kuhn U; Schmidt U; Ploch M; Murck H
J Psychiatr Res; 2010 Sep; 44(12):760-7. PubMed ID: 20181361
[TBL] [Abstract][Full Text] [Related]
5. St John's wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: continuation data from a 26-week RCT.
Sarris J; Fava M; Schweitzer I; Mischoulon D
Pharmacopsychiatry; 2012 Nov; 45(7):275-8. PubMed ID: 22592504
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
Lecrubier Y; Clerc G; Didi R; Kieser M
Am J Psychiatry; 2002 Aug; 159(8):1361-6. PubMed ID: 12153829
[TBL] [Abstract][Full Text] [Related]
7. Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298].
Kasper S; Anghelescu IG; Szegedi A; Dienel A; Kieser M
BMC Med; 2006 Jun; 4():14. PubMed ID: 16796730
[TBL] [Abstract][Full Text] [Related]
8. Routinely accessible parameters of mineralocorticoid receptor function, depression subtypes and response prediction: a post-hoc analysis from the early medication change trial in major depressive disorder.
Engelmann J; Murck H; Wagner S; Zillich L; Streit F; Herzog DP; Braus DF; Tadic A; Lieb K; Műller MB
World J Biol Psychiatry; 2022 Oct; 23(8):631-642. PubMed ID: 34985381
[TBL] [Abstract][Full Text] [Related]
9. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M
Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
[TBL] [Abstract][Full Text] [Related]
10. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
11. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study.
Brenner R; Azbel V; Madhusoodanan S; Pawlowska M
Clin Ther; 2000 Apr; 22(4):411-9. PubMed ID: 10823363
[TBL] [Abstract][Full Text] [Related]
12. St. John's wort and Kava in treating major depressive disorder with comorbid anxiety: a randomised double-blind placebo-controlled pilot trial.
Sarris J; Kavanagh DJ; Deed G; Bone KM
Hum Psychopharmacol; 2009 Jan; 24(1):41-8. PubMed ID: 19090505
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM
J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial.
Kalb R; Trautmann-Sponsel RD; Kieser M
Pharmacopsychiatry; 2001 May; 34(3):96-103. PubMed ID: 11434406
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled, dose-ranging study of lisdexamfetamine dimesylate augmentation for major depressive disorder in adults with inadequate response to antidepressant therapy.
Richards C; Iosifescu DV; Mago R; Sarkis E; Reynolds J; Geibel B; Dauphin M
J Psychopharmacol; 2017 Sep; 31(9):1190-1203. PubMed ID: 28857719
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of St. John's Wort in patients with minor depressive symptoms or dysthymia--a double-blind placebo-controlled study.
Randløv C; Mehlsen J; Thomsen CF; Hedman C; von Fircks H; Winther K
Phytomedicine; 2006 Mar; 13(4):215-21. PubMed ID: 16423519
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study.
Otte C; Hinkelmann K; Moritz S; Yassouridis A; Jahn H; Wiedemann K; Kellner M
J Psychiatr Res; 2010 Apr; 44(6):339-46. PubMed ID: 19909979
[TBL] [Abstract][Full Text] [Related]
18. A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.
Barbee JG; Thompson TR; Jamhour NJ; Stewart JW; Conrad EJ; Reimherr FW; Thompson PM; Shelton RC
J Clin Psychiatry; 2011 Oct; 72(10):1405-12. PubMed ID: 21367355
[TBL] [Abstract][Full Text] [Related]
19. Safety of Hypericum extract in mildly to moderately depressed outpatients: a review based on data from three randomized, placebo-controlled trials.
Trautmann-Sponsel RD; Dienel A
J Affect Disord; 2004 Oct; 82(2):303-7. PubMed ID: 15488262
[TBL] [Abstract][Full Text] [Related]
20. Conditional probability of response or nonresponse of placebo compared with antidepressants or St John's Wort in major depressive disorder.
Sarris J; Nierenberg AA; Schweitzer I; Alpert JE; Rosenbaum JF; Iovieno N; Covino J; Fava M; Mischoulon D
J Clin Psychopharmacol; 2013 Dec; 33(6):827-30. PubMed ID: 24091858
[No Abstract] [Full Text] [Related]
[Next] [New Search]
